Search

Your search keyword '"inflammatory bone destruction"' showing total 9 results

Search Constraints

Start Over You searched for: Descriptor "inflammatory bone destruction" Remove constraint Descriptor: "inflammatory bone destruction" Database MEDLINE Remove constraint Database: MEDLINE
9 results on '"inflammatory bone destruction"'

Search Results

1. JAK inhibition ameliorates bone destruction by simultaneously targeting mature osteoclasts and their precursors.

2. Differential effects of anti-RANKL monoclonal antibody and zoledronic acid on necrotic bone in a murine model of Staphylococcus aureus-induced osteomyelitis.

3. IL-35 and RANKL Synergistically Induce Osteoclastogenesis in RAW264 Mouse Monocytic Cells.

4. Suppression of hematopoietic cell kinase ameliorates the bone destruction associated with inflammation.

5. Interleukin-37 inhibits osteoclastogenesis and alleviates inflammatory bone destruction.

6. Gold Clusters Prevent Inflammation-Induced Bone Erosion through Inhibiting the Activation of NF-κB Pathway.

7. IL-15 and RANKL Play a Synergistically Important Role in Osteoclastogenesis.

8. Lectin-like oxidized low-density lipoprotein receptor-1 abrogation causes resistance to inflammatory bone destruction in mice, despite promoting osteoclastogenesis in the steady state.

9. The orally available Btk inhibitor ibrutinib (PCI-32765) protects against osteoclast-mediated bone loss.

Catalog

Books, media, physical & digital resources